Dr. Shin Enosawa, Japan
First‑in‑human trial of the treatment with human embryonic stem (ES) cell-derived hepatocyte-like cells for infantile urea cycle disorders

Dr. Carole Guillonneau, France
Advancing CD8+ Treg cell therapy to the clinic for the treatment of kidney transplanted patients

Dr. Denis Efimov, Belarus
Clinical implementation of advanced biotechnologies for liver failure management in Belarus: stem cell therapies and tissue engineering approaches

Prof. Camillo Ricordi, United States
Long-term islet graft function, improved insulin secretion and continued function after discontinuation of immunosuppression in islet allograft recipients treated with GLP-1 Receptor Agonists as adjunct therapy

Dr. Masayuki Kuroda, Japan
Autologous transplantation of LCAT gene-transduced adipocytes enabled long-term LCAT replacement in a patient with LCAT deficiency in first in human clinical trial